Search results
Results from the WOW.Com Content Network
2025 - Vienna; After the 2017 ESC Congress, Barcelona became the city with most congresses since 1988(6), followed by Stockholm (5) and then by Amsterdam and Vienna and Munich (4 times each as of 2018). Some congresses (1994 and 2006) were organised jointly with the World Heart Federation [2] under the name of "World Congress of Cardiology".
JACC: Cardiovascular Intervention is a peer-reviewed sub-specialty medical journal published by Elsevier for the American College of Cardiology since 2008. The journal focus on articles on interventional cardiology, encompassing cardiac coronary and non-coronary interventions, including peripheral arteries and cerebrovasculature (e.g., carotid artery).
The European Society of Cardiology (ESC) is an independent non-profit, non-governmental professional association that works to advance the prevention, diagnosis and management of diseases of the heart and blood vessels, and improve scientific understanding of the heart and vascular system. [2]
Circulation: Cardiovascular Intervention is a monthly peer-reviewed medical journal published by Lippincott Williams & Wilkins for the American Heart Association. [1] It focuses on interventional techniques for the surgical treatment of vascular disease, coronary artery disease, and structural heart disease. [2]
Pages in category "Interventional cardiology" The following 34 pages are in this category, out of 34 total. This list may not reflect recent changes. ...
Interventional cardiology is a branch of cardiology that deals specifically with the catheter based treatment of structural heart diseases. Andreas Gruentzig is considered the father of interventional cardiology after the development of angioplasty by interventional radiologist Charles Dotter .
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
Deepak L. Bhatt is a US interventional cardiologist, researcher, and educator.He is known for novel clinical trials in cardiovascular prevention, intervention, and heart failure.